|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaalmost 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketalmost 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themalmost 9 years ago
Reducing the Risk of Noncompliancealmost 9 years ago
When You Need Experts, Use Themalmost 9 years ago
Pricing Pressures and Policy Changesalmost 9 years ago
Not Your Typical Pharma Datelinealmost 9 years ago
Market Access: Current and Future Statesalmost 9 years ago
Market Access: A UK Perspectivealmost 9 years ago
Country Report: SingaporeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
